Display Settings:

Format

Send to:

Choose Destination
    Nephron Clin Pract. 2008;110(3):c158-63. Epub 2008 Oct 27.

    Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa.

    Source

    Department of Nephrology, University of Liège, Liège, Belgium. pierre_delanaye@yahoo.fr

    Abstract

    BACKGROUND:

    Patients with anorexia nervosa (AN) are at a high risk of renal failure. Chronic kidney disease (CKD) is often missed in these patients because the serum creatinine is a poor marker of kidney function. We studied the utility of cystatin C to detect renal failure in this population.

    METHOD:

    Twenty-seven AN patients were studied. Glomerular filtration rates (GFR) were measured with the chromium-51- ethylenediaminetetraacetate ((51)Cr-EDTA) method. We compared the ability of creatinine and cystatin C to detect stage 3 CKD (GFR below 60 ml/min) by ROC curve analysis.

    RESULTS:

    In this cohort, there is no correlation between GFR and serum creatinine, but there is a significant correlation between cystatin C and GFR. By ROC analysis, the cystatin C concentration is better than the serum creatinine concentration for the detection of stage 3 CKD (area under the curve of 0.86 vs. 0.61, p = 0.05).

    CONCLUSION:

    Plasma cystatin C is better than serum creatinine in detecting stage 3 CKD in patients with AN.

    Copyright 2008 S. Karger AG, Basel.

    PMID:
    18953178
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for S. Karger AG, Basel, Switzerland

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk